Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma

Background: Periostin and human chitinase-3-like protein 1 (YKL-40) have been suggested to be involved in the development of airway fibrosis and remodeling. This study aimed to investigate the relationship between serum periostin levels and airway hyperresponsiveness (AHR) and between serum YKL-40 l...

Full description

Saved in:
Bibliographic Details
Main Authors: Su Ji Kim, MD, Youn Joo Choi, MD, Man Yong Han, MD, PhD, Il Tae Hwang, MD, PhD, Hey-Sung Baek, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455124001236
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850285099530059776
author Su Ji Kim, MD
Youn Joo Choi, MD
Man Yong Han, MD, PhD
Il Tae Hwang, MD, PhD
Hey-Sung Baek, MD, PhD
author_facet Su Ji Kim, MD
Youn Joo Choi, MD
Man Yong Han, MD, PhD
Il Tae Hwang, MD, PhD
Hey-Sung Baek, MD, PhD
author_sort Su Ji Kim, MD
collection DOAJ
description Background: Periostin and human chitinase-3-like protein 1 (YKL-40) have been suggested to be involved in the development of airway fibrosis and remodeling. This study aimed to investigate the relationship between serum periostin levels and airway hyperresponsiveness (AHR) and between serum YKL-40 levels and AHR in children with asthma, comparing periostin as a marker for Th2 inflammation and atopy with YKL-40. Methods: The study involved children aged 6–15 years, comprising 75 with asthma and 29 healthy controls. We measured serum periostin and YKL-40 levels and performed exercise bronchial provocation tests, methacholine challenge tests, spirometry, and FeNO measurements. Results: Compared to the healthy controls, asthmatic children exhibited significantly elevated levels of periostin (86.7 [71.0–104.0] vs 68.3 [56.0–82.0] ng/mL; P = 0.006) and YKL-40 (29.0 [15.0–39.5] vs 27.7 [14.0–34.1] ng/mL; P = 0.034). The subgroup analysis revealed that periostin levels were significantly higher in the atopic asthma group than in the healthy controls (P = 0.003), but not in the non-atopic asthma group. YKL-40 levels were elevated in both the atopic and non-atopic asthma groups compared to healthy controls (P = 0.012 and P = 0.001, respectively). Serum periostin levels were significantly correlated with the postexerceise maximum percentage decrease in forced expiratory volume (FEV1), as well as with fractional exhaled nitric oxide (FeNO) and blood eosinophil counts, but showed no significant correlation with overall lung function. Conversely, serum YKL-40 levels were significantly linked to the Z score of FEV1 and AHR to methacholine but not with AHR to exercise or FeNO or blood eosinophil count. Conclusions: Periostin is linked to atopic asthma and correlates with exercise-induced bronchoconstriction, FeNO, and eosinophil counts, highlighting its role in Th2 inflammation. YKL-40 is a general asthma marker, indicating airway remodeling. These findings suggest that targeting these markers can improve personalized treatment strategies for pediatric asthma.
format Article
id doaj-art-4965f6a32a9145b8a1f5333099d03fa1
institution OA Journals
issn 1939-4551
language English
publishDate 2024-11-01
publisher Elsevier
record_format Article
series World Allergy Organization Journal
spelling doaj-art-4965f6a32a9145b8a1f5333099d03fa12025-08-20T01:47:23ZengElsevierWorld Allergy Organization Journal1939-45512024-11-01171110099110.1016/j.waojou.2024.100991Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthmaSu Ji Kim, MD0Youn Joo Choi, MD1Man Yong Han, MD, PhD2Il Tae Hwang, MD, PhD3Hey-Sung Baek, MD, PhD4Department of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South KoreaDepartment of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South KoreaDepartments of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South KoreaDepartment of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South KoreaDepartment of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea; Corresponding author. Department of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Seongan-ro, Gangdong-gu, Seoul, 035355, South Korea.Background: Periostin and human chitinase-3-like protein 1 (YKL-40) have been suggested to be involved in the development of airway fibrosis and remodeling. This study aimed to investigate the relationship between serum periostin levels and airway hyperresponsiveness (AHR) and between serum YKL-40 levels and AHR in children with asthma, comparing periostin as a marker for Th2 inflammation and atopy with YKL-40. Methods: The study involved children aged 6–15 years, comprising 75 with asthma and 29 healthy controls. We measured serum periostin and YKL-40 levels and performed exercise bronchial provocation tests, methacholine challenge tests, spirometry, and FeNO measurements. Results: Compared to the healthy controls, asthmatic children exhibited significantly elevated levels of periostin (86.7 [71.0–104.0] vs 68.3 [56.0–82.0] ng/mL; P = 0.006) and YKL-40 (29.0 [15.0–39.5] vs 27.7 [14.0–34.1] ng/mL; P = 0.034). The subgroup analysis revealed that periostin levels were significantly higher in the atopic asthma group than in the healthy controls (P = 0.003), but not in the non-atopic asthma group. YKL-40 levels were elevated in both the atopic and non-atopic asthma groups compared to healthy controls (P = 0.012 and P = 0.001, respectively). Serum periostin levels were significantly correlated with the postexerceise maximum percentage decrease in forced expiratory volume (FEV1), as well as with fractional exhaled nitric oxide (FeNO) and blood eosinophil counts, but showed no significant correlation with overall lung function. Conversely, serum YKL-40 levels were significantly linked to the Z score of FEV1 and AHR to methacholine but not with AHR to exercise or FeNO or blood eosinophil count. Conclusions: Periostin is linked to atopic asthma and correlates with exercise-induced bronchoconstriction, FeNO, and eosinophil counts, highlighting its role in Th2 inflammation. YKL-40 is a general asthma marker, indicating airway remodeling. These findings suggest that targeting these markers can improve personalized treatment strategies for pediatric asthma.http://www.sciencedirect.com/science/article/pii/S1939455124001236PeriostinChitinase-like proteins (YKL-40)AsthmaAirway hyperresponsiveness
spellingShingle Su Ji Kim, MD
Youn Joo Choi, MD
Man Yong Han, MD, PhD
Il Tae Hwang, MD, PhD
Hey-Sung Baek, MD, PhD
Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
World Allergy Organization Journal
Periostin
Chitinase-like proteins (YKL-40)
Asthma
Airway hyperresponsiveness
title Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
title_full Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
title_fullStr Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
title_full_unstemmed Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
title_short Evaluating serum periostin and YKL-40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
title_sort evaluating serum periostin and ykl 40 as biomarkers for airway remodeling and hyperresponsiveness in pediatric asthma
topic Periostin
Chitinase-like proteins (YKL-40)
Asthma
Airway hyperresponsiveness
url http://www.sciencedirect.com/science/article/pii/S1939455124001236
work_keys_str_mv AT sujikimmd evaluatingserumperiostinandykl40asbiomarkersforairwayremodelingandhyperresponsivenessinpediatricasthma
AT younjoochoimd evaluatingserumperiostinandykl40asbiomarkersforairwayremodelingandhyperresponsivenessinpediatricasthma
AT manyonghanmdphd evaluatingserumperiostinandykl40asbiomarkersforairwayremodelingandhyperresponsivenessinpediatricasthma
AT iltaehwangmdphd evaluatingserumperiostinandykl40asbiomarkersforairwayremodelingandhyperresponsivenessinpediatricasthma
AT heysungbaekmdphd evaluatingserumperiostinandykl40asbiomarkersforairwayremodelingandhyperresponsivenessinpediatricasthma